Michael Schmidt
Stock Analyst at Guggenheim
(4.31)
# 397
Out of 4,911 analysts
109
Total ratings
59.09%
Success rate
14.07%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Michael Schmidt
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COGT Cogent Biosciences | Reiterates: Buy | $17 | $12.07 | +40.85% | 1 | Jul 8, 2025 | |
| RVMD Revolution Medicines | Reiterates: Buy | $80 | $37.91 | +111.05% | 4 | Jun 25, 2025 | |
| AVBP ArriVent BioPharma | Reiterates: Buy | $45 | $21.20 | +112.26% | 2 | Jun 24, 2025 | |
| ADCT ADC Therapeutics | Maintains: Buy | $7 → $10 | $3.28 | +204.88% | 5 | Jun 13, 2025 | |
| URGN UroGen Pharma | Maintains: Buy | $40 → $15 | $18.95 | -20.84% | 1 | May 23, 2025 | |
| MRSN Mersana Therapeutics | Reiterates: Buy | $5 | $0.31 | +1,523.38% | 3 | May 16, 2025 | |
| KYMR Kymera Therapeutics | Reiterates: Buy | $52 | $45.79 | +13.56% | 1 | May 12, 2025 | |
| CMPX Compass Therapeutics | Maintains: Buy | $12 → $10 | $3.18 | +214.47% | 4 | May 9, 2025 | |
| ONC BeOne Medicines | Maintains: Buy | $348 → $350 | $291.47 | +20.08% | 3 | May 8, 2025 | |
| RLAY Relay Therapeutics | Maintains: Buy | $30 → $10 | $3.74 | +167.38% | 1 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $32 | $9.63 | +232.29% | 3 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $16 | $7.84 | +104.08% | 5 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $6.81 | +17.47% | 2 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $109 | $66.82 | +63.12% | 5 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $1.75 | $0.35 | +404.47% | 3 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $14 | $6.14 | +128.01% | 3 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $25 | $10.87 | +129.99% | 2 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $92 | $70.20 | +31.05% | 5 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $43.36 | - | 1 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $11.44 | - | 5 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $42 | $45.60 | -7.89% | 10 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $0.63 | - | 1 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $3.33 | +500.60% | 1 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $1.47 | +444.22% | 3 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $35.22 | - | 3 | Oct 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $6.43 | - | 2 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.06 | - | 2 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.50 | - | 1 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $34 | $9.24 | +268.16% | 4 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $20 | $0.77 | +2,492.35% | 3 | Jun 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $23.40 | - | 2 | Jan 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $1.74 | +1,336.78% | 1 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $5.68 | +428.17% | 1 | Jul 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $26 | $3.72 | +598.17% | 1 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.52 | - | 2 | Apr 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $80 | $40.01 | +99.95% | 5 | Feb 15, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $6.91 | - | 6 | Jan 17, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $4 → $5.5 | $3.22 | +71.07% | 2 | Nov 7, 2017 |
Cogent Biosciences
Jul 8, 2025
Reiterates: Buy
Price Target: $17
Current: $12.07
Upside: +40.85%
Revolution Medicines
Jun 25, 2025
Reiterates: Buy
Price Target: $80
Current: $37.91
Upside: +111.05%
ArriVent BioPharma
Jun 24, 2025
Reiterates: Buy
Price Target: $45
Current: $21.20
Upside: +112.26%
ADC Therapeutics
Jun 13, 2025
Maintains: Buy
Price Target: $7 → $10
Current: $3.28
Upside: +204.88%
UroGen Pharma
May 23, 2025
Maintains: Buy
Price Target: $40 → $15
Current: $18.95
Upside: -20.84%
Mersana Therapeutics
May 16, 2025
Reiterates: Buy
Price Target: $5
Current: $0.31
Upside: +1,523.38%
Kymera Therapeutics
May 12, 2025
Reiterates: Buy
Price Target: $52
Current: $45.79
Upside: +13.56%
Compass Therapeutics
May 9, 2025
Maintains: Buy
Price Target: $12 → $10
Current: $3.18
Upside: +214.47%
BeOne Medicines
May 8, 2025
Maintains: Buy
Price Target: $348 → $350
Current: $291.47
Upside: +20.08%
Relay Therapeutics
May 7, 2025
Maintains: Buy
Price Target: $30 → $10
Current: $3.74
Upside: +167.38%
May 6, 2025
Reiterates: Buy
Price Target: $32
Current: $9.63
Upside: +232.29%
May 2, 2025
Maintains: Buy
Price Target: $32 → $16
Current: $7.84
Upside: +104.08%
Apr 4, 2025
Maintains: Buy
Price Target: $12 → $8
Current: $6.81
Upside: +17.47%
Mar 28, 2025
Reiterates: Buy
Price Target: $109
Current: $66.82
Upside: +63.12%
Mar 26, 2025
Maintains: Buy
Price Target: $3 → $1.75
Current: $0.35
Upside: +404.47%
Mar 24, 2025
Maintains: Buy
Price Target: $13 → $14
Current: $6.14
Upside: +128.01%
Mar 20, 2025
Maintains: Buy
Price Target: $35 → $25
Current: $10.87
Upside: +129.99%
Mar 18, 2025
Downgrades: Neutral
Price Target: $92
Current: $70.20
Upside: +31.05%
Mar 12, 2025
Reiterates: Neutral
Price Target: n/a
Current: $43.36
Upside: -
Feb 26, 2025
Reiterates: Buy
Price Target: n/a
Current: $11.44
Upside: -
Feb 12, 2025
Reiterates: Buy
Price Target: $42
Current: $45.60
Upside: -7.89%
Jan 22, 2025
Reiterates: Buy
Price Target: n/a
Current: $0.63
Upside: -
Dec 6, 2024
Reiterates: Buy
Price Target: $20
Current: $3.33
Upside: +500.60%
Nov 15, 2024
Maintains: Buy
Price Target: $12 → $8
Current: $1.47
Upside: +444.22%
Oct 7, 2024
Downgrades: Neutral
Price Target: n/a
Current: $35.22
Upside: -
May 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $6.43
Upside: -
Mar 14, 2024
Downgrades: Neutral
Price Target: n/a
Current: $4.06
Upside: -
Jan 5, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.50
Upside: -
Nov 8, 2023
Maintains: Buy
Price Target: $40 → $34
Current: $9.24
Upside: +268.16%
Jun 27, 2023
Downgrades: Neutral
Price Target: $20
Current: $0.77
Upside: +2,492.35%
Jan 3, 2022
Downgrades: Neutral
Price Target: n/a
Current: $23.40
Upside: -
Aug 10, 2021
Initiates: Buy
Price Target: $25
Current: $1.74
Upside: +1,336.78%
Jul 19, 2021
Initiates: Buy
Price Target: $30
Current: $5.68
Upside: +428.17%
May 18, 2021
Initiates: Buy
Price Target: $26
Current: $3.72
Upside: +598.17%
Apr 28, 2021
Downgrades: Neutral
Price Target: n/a
Current: $2.52
Upside: -
Feb 15, 2019
Upgrades: Outperform
Price Target: $80
Current: $40.01
Upside: +99.95%
Jan 17, 2019
Initiates: Outperform
Price Target: n/a
Current: $6.91
Upside: -
Nov 7, 2017
Maintains: Market Perform
Price Target: $4 → $5.5
Current: $3.22
Upside: +71.07%